Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
07 05 2019
Historique:
received: 21 01 2019
accepted: 21 01 2019
entrez: 4 5 2019
pubmed: 3 5 2019
medline: 4 3 2020
Statut: ppublish

Résumé

Exercise intolerance is the cardinal symptom of heart failure (HF) and is of crucial relevance, because it is associated with a poor quality of life and increased mortality. While impaired cardiac reserve is considered to be central in HF, reduced exercise and functional capacity are the result of key patient characteristics and multisystem dysfunction, including aging, impaired pulmonary reserve, as well as peripheral and respiratory skeletal muscle dysfunction. We herein review the different modalities to quantify exercise intolerance, the pathophysiology of HF, and comorbid conditions as they lead to reductions in exercise and functional capacity, highlighting the fact that distinct causes may coexist and variably contribute to exercise intolerance in patients with HF.

Identifiants

pubmed: 31047010
pii: S0735-1097(19)33923-3
doi: 10.1016/j.jacc.2019.01.072
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2209-2225

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Marco Giuseppe Del Buono (MG)

VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia; Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy.

Ross Arena (R)

Department of Physical Therapy, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, Illinois; Total Cardiology Research Network, Calgary, Alberta, Canada.

Barry A Borlaug (BA)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

Salvatore Carbone (S)

VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Justin M Canada (JM)

VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Danielle L Kirkman (DL)

Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia.

Ryan Garten (R)

Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia.

Paula Rodriguez-Miguelez (P)

Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia.

Marco Guazzi (M)

Cardiology University Department, Heart Failure Unit, University of Milan, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Carl J Lavie (CJ)

Department of Cardiovascular Diseases, Ochsner Clinical School, New Orleans, Louisiana.

Antonio Abbate (A)

VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia. Electronic address: antonio.abbate@vcuhealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH